These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31187915)

  • 1. Network spread determines severity of degeneration and disconnection in Huntington's disease.
    Poudel GR; Harding IH; Egan GF; Georgiou-Karistianis N
    Hum Brain Mapp; 2019 Oct; 40(14):4192-4201. PubMed ID: 31187915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network model of pathology spread recapitulates neurodegeneration and selective vulnerability in Huntington's Disease.
    Raj A; Powell F
    Neuroimage; 2021 Jul; 235():118008. PubMed ID: 33789134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
    McColgan P; Seunarine KK; Razi A; Cole JH; Gregory S; Durr A; Roos RA; Stout JC; Landwehrmeyer B; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
    Brain; 2015 Nov; 138(Pt 11):3327-44. PubMed ID: 26384928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for the selective subcortical degeneration in Huntington's disease.
    Douaud G; Behrens TE; Poupon C; Cointepas Y; Jbabdi S; Gaura V; Golestani N; Krystkowiak P; Verny C; Damier P; Bachoud-Lévi AC; Hantraye P; Remy P
    Neuroimage; 2009 Jul; 46(4):958-66. PubMed ID: 19332141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques.
    Rizk-Jackson A; Stoffers D; Sheldon S; Kuperman J; Dale A; Goldstein J; Corey-Bloom J; Poldrack RA; Aron AR
    Neuroimage; 2011 May; 56(2):788-96. PubMed ID: 20451620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
    Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
    Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.
    Reading SA; Yassa MA; Bakker A; Dziorny AC; Gourley LM; Yallapragada V; Rosenblatt A; Margolis RL; Aylward EH; Brandt J; Mori S; van Zijl P; Bassett SS; Ross CA
    Psychiatry Res; 2005 Oct; 140(1):55-62. PubMed ID: 16199141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.
    De Paepe AE; Sierpowska J; Garcia-Gorro C; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E
    Neuroimage Clin; 2019; 24():101965. PubMed ID: 31401404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits.
    Bohanna I; Georgiou-Karistianis N; Sritharan A; Asadi H; Johnston L; Churchyard A; Egan G
    Brain Imaging Behav; 2011 Sep; 5(3):171-80. PubMed ID: 21437574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease.
    Rosas HD; Wilkens P; Salat DH; Mercaldo ND; Vangel M; Yendiki AY; Hersch SM
    Neuroimage Clin; 2018; 20():236-242. PubMed ID: 30090698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
    Shaffer JJ; Ghayoor A; Long JD; Kim RE; Lourens S; O'Donnell LJ; Westin CF; Rathi Y; Magnotta V; Paulsen JS; Johnson HJ
    Hum Brain Mapp; 2017 Mar; 38(3):1460-1477. PubMed ID: 28045213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.
    Minkova L; Eickhoff SB; Abdulkadir A; Kaller CP; Peter J; Scheller E; Lahr J; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Hum Brain Mapp; 2016 Jan; 37(1):67-80. PubMed ID: 26453902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
    Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
    Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
    Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.
    Gatto RG; Chu Y; Ye AQ; Price SD; Tavassoli E; Buenaventura A; Brady ST; Magin RL; Kordower JH; Morfini GA
    Hum Mol Genet; 2015 Sep; 24(18):5285-98. PubMed ID: 26123489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.